周四,诺瓦瓦克斯医药(NVAX.US)盘中股价出现大涨,一度上涨逾5%,引发市场关注。截至收盘,该股报收于13.32美元,较前一交易日上涨5.05%,成交量153.6万股,换手率0.96%,全天振幅达5.52%。
公开资料显示,此番股价大涨的主要原因,与莱利金融分析师Mayank Mamtani维持该股"买入"评级并上调目标价至26美元不无关系。由于分析师给予利好评级和预期,投资者对诺瓦瓦克斯医药的未来业绩前景重拾信心,从而推动股价出现大幅上涨。
公司最新财报数据显示,诺瓦瓦克斯医药今年第三季度实现营收4.15亿美元,净利润1.62亿美元,每股收益1.09美元。目前该股的市盈率为-5.06倍,总体估值仍然较为合理。未来,分析机构对其业绩反弹给予积极评价,也将利好其股价表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.